Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
4 drugs in development
By Therapeutic Area
top 1
R&D Momentum
65/100
Pipeline Velocity
22/100
Trial Completion Rate
87/100
Pipeline Concentration
63/100
Pipeline Freshness
55/100
Strategic Signals
Activity
Last 14 days
Tissue Penetration of Paracetamol and Exposure to Toxic Metabolites in Paediatric Intensive Care Patients (TIPPIC)
MetAbolic Changes in the SepSis LIVEr
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)